SyntekaBio's Largest Shareholder Jongseon Jeong Partially Repays Share Pledge Loan, Reducing Principal from 3.15B to 2.85B Won, Easing Financial Pressure

SyntekaBio's largest shareholder Jongseon Jeong amended the substantial shareholding report originally filed on May 28, 2026, disclosing that the share pledge loan principal was reduced from 3.15 billion won to 2.85 billion won, a decrease of 300 million won.
The number of pledged shares remains unchanged at 2.8 million shares representing 11.54% of outstanding shares. The loan reduction improves the loan-to-value ratio from 72% to 65% against the 160% maintenance requirement, lowering margin call risk.
The total shareholding of the reporting person and his specially related persons remains at 3,807,031 shares or 15.69% of outstanding shares, unchanged from the previous report, with no direct impact on control.
[AI Summary]This amendment reflects a partial repayment of the largest shareholder's stock pledge loan. While it is an administrative correction with no change in share count or pledged quantity, the reduction in loan principal signals improved financial health for the controlling shareholder. However, the high 12% interest rate and short-term loan structure still warrant monitoring.